ICD-10-CM 2026 · Effective October 1, 2025

ICD-10 C50.A0

Billable / Specific HCC v28: 12

Malignant inflammatory neoplasm of unspecified breast

C50
Block
0
Synonyms
249
LCDs
15
Payer Policies
0
Linked CPTs

About ICD-10-CM C50.A0

ICD-10-CM code C50.A0 represents Malignant inflammatory neoplasm of unspecified breast. This is a billable/specific code in the chapter (block C50). The 2026 edition of ICD-10-CM C50.A0 became effective on October 1, 2025.

Coding Tips for C50.A0

Specialist guidance from the PayerReady Medical Coding Team. Specificity warnings, HCC capture rules, sequencing notes.

HCC capture: document with MEAT each year

C50.A0 is a CMS-HCC v28 risk-adjustment code (category 12). To count for the patient Risk Adjustment Factor (RAF), document the diagnosis with MEAT language each calendar year: Monitored, Evaluated, Assessed, Treated. A diagnosis on the problem list alone does not satisfy CMS RADV audit standards. Include the diagnosis in the assessment with current status and current treatment plan.

Medicare Advantage HCC Impact

CMS-HCC v28 (current)
Category 12
ESRD-HCC
Category 12
RxHCC (Part D)
Category 12

Capture this diagnosis annually for accurate risk adjustment. Missed HCC captures are the #1 revenue leak in Medicare Advantage risk programs.

Medicare LCD Coverage for C50.A0

Local Coverage Determinations (LCDs) from CMS MACs that list C50.A0 as a covered diagnosis.

249 LCDs

Showing top 10 of 249 total . Click a CPT for full coverage scope.

CMS LCD: Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
Article ID: 55294, Effective: 2026-02-19 00:00:00, 68 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
Article ID: 55294, Effective: 2026-02-19 00:00:00, 68 covered, 0 non-covered
CPT 81162 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81215 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81300 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81351 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81167 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81405 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 0103U →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81201 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81297 →

Commercial Payer Coverage

Coverage policies from major commercial payers referencing C50.A0.

15 policies

5 Medicare

External Breast Prostheses - Policy Article
Policy ID: ART-52478
Oral Anticancer Drugs - Policy Article
Policy ID: ART-52479
Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
Policy ID: ART-52480
Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
Policy ID: ART-54338
Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
Policy ID: ART-55224

CPT Codes Commonly Billed with C50.A0

Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.

No procedure linkages on file for C50.A0

We don't have CPT pairings indexed for this specific code yet. Use the CPT search above to find common procedures, or check your payer's published medical policy for code-specific guidance.

ICD-10 C50.A0, Billing FAQ

Is ICD-10 code C50.A0 billable? +

Yes, C50.A0 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.

Does C50.A0 affect Medicare Advantage HCC risk adjustment? +

Yes. C50.A0 maps to CMS-HCC v28 category 12. Capture this diagnosis annually for accurate Medicare Advantage risk score.

Get the full PayerReady toolkit

Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.

Start free →

Run this code through our claim audit tool

Check NCCI bundling, MUE limits, and modifier logic before submission.

Try the auditor →

Did this page help?

Quick signal so we know what to improve.

Thanks!

If you want a code reference page that doesn't exist yet, email coding@payerready.com.

Sorry to hear that.

Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.

Reviewed by the PayerReady Medical Coding Team

Verified against the CMS 2026 code set on May 31, 2026.

Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team

Faster Approvals

Ready to Cut Your Enrollment Timeline in Half?

Join providers in all 50 states who handed off credentialing to a dedicated specialist. Create your free account in minutes and start enrolling the same day.

All 50 States Covered
No Long-Term Contracts
HIPAA HIPAA Compliant Platform
Dedicated Specialist Included